Get the Stockscreener App
261.44
1.93%
4.96
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $261.44, with a volume of 5.46M.
It is up +1.93% in the last 24 hours and down -2.11% over the past month.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
See More
Previous Close:
$256.48
Open:
$255.09
24h Volume:
5.46M
Relative Volume:
0.82
Market Cap:
$630.04B
Revenue:
$97.93B
Net Income/Loss:
$21.04B
P/E Ratio:
30.30
EPS:
8.6278
Net Cash Flow:
$17.80B
1W Performance:
+2.11%
1M Performance:
-2.11%
6M Performance:
+8.34%
1Y Performance:
+36.82%
1-Day Range:
$254.99
$261.61
1-Week Range:
$251.17
$261.61
52-Week Range:
$184.66
$281.07
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ vs LLY, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
261.44 | 622.84B | 97.93B | 21.04B | 17.80B | 8.6278 |
LLY
Lilly Eli Co
|
1,179.27 | 1.06T | 72.25B | 25.28B | 10.37B | 27.78 |
ABBV
Abbvie Inc
|
276.47 | 481.40B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
145.60 | 354.80B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
143.75 | 268.10B | 54.66B | 13.58B | 16.05B | 7.0171 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-26 | Resumed | UBS | Buy |
| May-13-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Apr-08-26 | Resumed | TD Cowen | Buy |
| Jan-28-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-20-25 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Oct-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-23-25 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-23-25 | Upgrade | Erste Group | Hold → Buy |
| May-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Artist Talk: Ralph Johnson on Architecture in a Rapidly Changing World - The Art Institute of Chicago
‘Inside the NBA’ to appear more often on ESPN and ABC this season - The New York Times
National Museum of Natural History’s Sant Director Kirk Johnson To Depart for the Denver Museum of Nature and Science - Smithsonian
Jets' Aaron Glenn looking forward to facing Ben Johnson, Bears: 'He's a damn good coach' - NFL.com
Ty Johnson: Getting Back In The Action, Facing An AFC East Opponent, And RBs He Idolizes - Buffalo Bills
Bears’ Jaylon Johnson Given Punishment by NFL for Ridiculous Reason - heavy.com
Reds to replace pitching coach Derek Johnson - The New York Times
Reds pitching coach Johnson not returning; search underway for replacement - MLB.com
Bears' Ben Johnson won't reveal Week 4 starting QB after Keenum stunner: 'Looking at everything' - NFL.com
Johnson & Johnson survey finds women not connecting menopause to eye health changes - Fierce Pharma
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause - Johnson & Johnson
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell? - Zacks Investment Research
Privilege in third party engagements: lessons from Singtel Optus and Medibank on the dominant purpose test - Johnson Winter Slattery
Congressional staff planned official trip with luxury stops in Italy and France weeks before election - NBC News
Bears will wait to announce starting QB for Jets game - Chicago Bears
Ben Johnson, Bears remain mum on starting QB decision for Week 4The Athletic - The New York Times
NFL news: Chicago Bears coach Ben Johnson considering options at quarterback, Case Keenum, Tyson Bagent, for New York Jets matchup - ABC7 Chicago
Bears' Ben Johnson: 'Direction already made' on Week 4 QB call - ESPN
Ben Johnson on Aaron Glenn, preparing for Jets | Press Conference - Chicago Bears
Back on the Road: Jets Travel to the Windy City as Aaron Glenn Encounters Ben Johnson's Bears - New York Jets
Obituary for Everette "Buster" Johnson - westsidechapelfuneralhome.com
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast - GlobeNewswire Inc.
A Mike Ditka, a Ben Johnson, and a kiss: Recently engaged fans score Monday Night Football moment at Chicago Bears game - ABC7 Chicago
Q. Johnson, T. Taylor Talk Vanderbilt - University of Georgia Athletics
'Verity' puts Anne Hathaway, Dakota Johnson and Josh Hartnett in a steamy Colleen Hoover thriller - News4JAX
Hill, Johnson Earn National Player of the Week Honors - goducks.com
Jenna Johnson and Val Chmerkovskiy Reveal Son Rome, 3, Was Hospitalized: ‘Sunday Funday’ - yahoo.com
Why Trump, Johnson and AI leaders are meeting at the White House - CBS News
Melva JohnsonCrumpler - Crumpler - Honeycutt Funeral Home
Lyndon B. JohnsonVietnam War, Civil Rights, Presidency - Britannica
Did Dakota Johnson tease the ‘Patient Zero’ video plot with her jewelry? - Page Six
Johnson & Johnson’s Next Growth Engine Is Taking Shape - 247wallst.com
Trump and Johnson to meet with tech CEOs on AI risk - Politico
Watch Taylor Swift Haunt Dakota Johnson and Colin Farrell in “Patient Zero” Video - yahoo.com
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance
C.J. Gardner-Johnson intercepts the Justin Herbert pass | Bills vs. Chargers HighlightsBuffalo Bills Home | Buffalo Bills - Buffalo Bills Home | Buffalo Bills - buffalobills.com
Obituary for Patricia E. Johnson - Crawford Osthus Funeral Chapel
Wendy Baptisme charged in Austin, Chicago shooting deaths of Deangelo Johnson, Angela Johnson on Parkside Avenue: police - ABC7 Chicago
Every member of the 3,000-strikeout club - MLB.com
Johnson goes into offseason with 'a little fire' after taking loss in final start - MLB.com
Bogle, Johnson break down Razorbacks’ win against Golden Hurricane - Arkansas Razorbacks
How New TREMFYA Data At Johnson & Johnson Stock Has Changed Its Investment Story - simplywall.st
Media Availability | Postgame vs. Kraken - NHL.com
Johnson Ties School Record as Terriers Roll to 7-2 Win at Bucknell in PL Opener - Boston University Athletics
Wolves Men Win Mike Johnson Classic - Western Oregon University Athletics
Ben Johnson: Players are 'fighting to be on that grass and help us win' | Press Conference - Chicago Bears
Bears coach Ben Johnson has been lauded as an offensive genius. Can he win without a No. 1 pick at quarterback? - NBC News
What Does Johnson & Johnson (JNJ) New Clinical Data Mean For Its Stock? - Yahoo Finance
The ‘7 Up’ series: didactic social history as masterpiece - Financial Times
Federal Leader’s Guide to CAIO & CDO: HHS’ Jennifer Johnson on how acquisition teams are prepping to integrate AI tools, drive efficiencies - Federal News Network
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):